NYSEARCA:MRNY YieldMax MRNA Option Income Strategy ETF (MRNY) Price, Holdings, & News $40.21 -1.60 (-3.83%) Closing price 04:10 PM EasternExtended Trading$39.84 -0.37 (-0.92%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsNews and TrendsShort Interest About YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MRNY alerts:Sign Up Key Stats Today's Range$38.65▼$40.5150-Day Range$14.22▼$42.0052-Week Range$13.60▼$42.63Volume512,731 shsAverage Volume243,641 shsMarket Capitalization$213.11 millionAssets Under Management$225.17 millionDividend Yield36.36%Net Expense Ratio1.00%Aggregate RatingN/A ETF Overview The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax. Read More YieldMax MRNA Option Income Strategy ETF ExpensesTypeMRNYSingle Stock ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.99%0.98%0.57%0.50%0.53%Other Expenses0.01%0.28%0.53%0.60%0.54%Total Expense1.00%1.19%0.75%0.75%0.73%Fee Waiver0.00%-0.43%-0.67%-0.78%-0.68%Net Expense1.00%1.07%0.63%0.57%0.60% Receive MRNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for YieldMax MRNA Option Income Strategy ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MRNY ETF News HeadlinesYieldMax MRNA Option Income Strategy ETF declares $0.6367 dividendSeptember 23, 2026 | seekingalpha.comYieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Stock Price Up 5.1% - Still a Buy?September 23, 2026 | americanbankingnews.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.September 30 at 1:00 AM | Stansberry Research (Ad)YieldMax MRNA option income strategy ETF declares $0.5672 dividendSeptember 17, 2026 | msn.comThe Melanoma Win Is Real, The Price Isn't - Moderna And MRNY Both SellSeptember 14, 2026 | seekingalpha.comYieldMax MRNA option income strategy ETF announces weekly distribution of $0.6420September 10, 2026 | msn.comSee More Headlines MRNY ETF - Frequently Asked Questions How have MRNY shares performed this year? YieldMax MRNA Option Income Strategy ETF's stock was trading at $14.70 on January 1st, 2026. Since then, MRNY stock has increased by 173.5% and is now trading at $40.21. When did YieldMax MRNA Option Income Strategy ETF's stock split? YieldMax MRNA Option Income Strategy ETF shares reverse split before market open on Monday, December 1st 2025.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, November 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of YieldMax MRNA Option Income Strategy ETF? Shares of MRNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of YieldMax MRNA Option Income Strategy ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that YieldMax MRNA Option Income Strategy ETF investors own include YieldMax NVDA Option Income Strategy ETF (NVDY), YieldMax COIN Option Income Strategy ETF (CONY), YieldMax META Option Income Strategy ETF (FBY), Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF (QQQY), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Oxford Lane Capital (OXLC) and YieldMax AMZN Option Income Strategy ETF (AMZY). Fund Details IssuerElevate Shares Fund NameYieldMax MRNA Option Income Strategy ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:MRNY Inception Date10/23/2023 Fund ManagerMick Brokaw, Jay Pestrichelli, Qiao Duan, Charles Ragauss WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusSingle Stock Development LevelDeveloped Markets RegionNorth America Number of Holdings17 Fund Statistics Assets Under Management$225.17 million Average Daily Volume$0.00 Discount/Premium0.15% Administrator, Advisor and Custodian AdministratorTidal ETF Services, LLC AdvisorTidal Investments, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerCitadel Options OptionableOptionable Options Volume25 Put Options3 Call Options22 Short Interest80,671 shs Miscellaneous Outstanding Shares5,300,000Beta0.14 Creation Fee$300.00 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report Top 10 MRNY HoldingsMrna 11/20/2026 135.01 CHolding Weight: 43.66%OTHER ASSETS AND LIABILITIESHolding Weight: 33.73%MRNA US 09/25/26 C165Holding Weight: 14.28%United States Treasury Bills 0%Holding Weight: 14.19%United States Treasury Notes 2.38%Holding Weight: 12.14%United States Treasury Bills 0%Holding Weight: 8.46%United States Treasury Bills 0%Holding Weight: 4.34%MRNA US 09/25/26 C167.5Holding Weight: 3.22%Cash OffsetHolding Weight: 1.40%First American Government Obligs XHolding Weight: 1.02%Full Holdings DetailsMRNY Sector ExposureMRNY Geographic Exposure This page (NYSEARCA:MRNY) was last updated on 9/30/2026 by MarketBeat.com Staff. From Our PartnersHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YieldMax MRNA Option Income Strategy ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share YieldMax MRNA Option Income Strategy ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.